FRAPUMA Trademark

Trademark Overview

On Wednesday, August 30, 2023, a trademark application was filed for FRAPUMA with the United States Patent and Trademark Office. The USPTO has given the FRAPUMA trademark a serial number of 79379356. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Eisai R&D Management Co., Ltd.. The FRAPUMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of mycetoma
frapuma

General Information

Serial Number79379356
Word MarkFRAPUMA
Filing DateWednesday, August 30, 2023
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7362461
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of mycetoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEisai R&D Management Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameEisai R&D Management Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameEisai R&D Management Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Monday, October 30, 2023ASSIGNED TO EXAMINER
Thursday, September 21, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, September 26, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, September 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 4, 2023APPLICATION FILING RECEIPT MAILED
Tuesday, October 31, 2023NON-FINAL ACTION WRITTEN
Wednesday, November 1, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, November 1, 2023REFUSAL PROCESSED BY MPU
Wednesday, November 1, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 21, 2023REFUSAL PROCESSED BY IB
Thursday, December 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 20, 2024NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, January 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024REGISTERED-PRINCIPAL REGISTER
Thursday, February 20, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Thursday, February 20, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, March 8, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Saturday, November 9, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, July 24, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 24, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 24, 2024FINAL DISPOSITION PROCESSED

Related Keywords

frapuma mycetoma treatment substances preparations pharmaceutical